CAPTRUST Financial Advisors
MBII

CAPTRUST Financial Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,130
Closed -$1K – 4618
2022
Q2 		$1K Hold
1,130
– – ﹤0.01% 4851
2022
Q1 		$1K Sell
1,130
-2,500
-69% -$1.89K ﹤0.01% 4824
2021
Q4 		$3K Hold
3,630
– – ﹤0.01% 4346
2021
Q3 		$3K Hold
3,630
– – ﹤0.01% 4185
2021
Q2 		$6K Buy
3,630
+1,630
+82% +$2.72K ﹤0.01% 3818
2021
Q1 		$4K Buy
+2,000
New +$4.15K ﹤0.01% 3842

CAPTRUST Financial Advisors's MBII Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 1,130 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in MBII in Q1 2021 and held it in 6 quarters. The position peaked at $6K in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,130 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Marrone Bio Innovations, Inc. position peaked at $6K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.